
Summary: Some companies are posting strong earnings growth, yet the market response has been unusually muted. This silence isn’t accidental. It reflects a deeper judgement about how durable that growth really is, and what still needs to be proven.
If you’ve ever tried to lose weight seriously, you may know the feeling: you show up at the gym regularly, follow a disciplined diet, push through the tough workouts, cut back on late nights — yet the number on the weighing scale barely moves. The effort is real, but the visible outcome is limited.
Something similar is playing out in parts of the Indian stock market. For years, strong growth expectations were enough to lift valuations. Investors paid up early, liquidity was abundant and optimism did the heavy lifting.
That phase is over. Over the past two years, liquidity has tightened, risk appetite has cooled and valuations have compressed. The result is an unusual pattern: several companies are reporting strong earnings, but their share prices have barely budged.
This disconnect is not accidental. It reflects a tougher question the market is now asking — not what has grown, but what can endure.
A tougher market demands tougher proof
To understand where this disconnect between earnings and share prices was most visible, we applied a screen designed for the current market – one that rewards execution, not mere optimism.
Our screen included the following filters:
- An annual growth of at least 25 per cent in both revenue and profit over the past three years
- A market capitalisation of Rs 5,000 crore and above
- Despite the growth, the company’s valuations had to contract meaningfully, with price-to-earnings (P/E) multiples falling by over 30 per cent from its peak, even as the stock delivered positive returns over the past year.
- Finally, operating cash flows had to be at least half of EBITDA over the same three-year period. This ensured profits were not just accounting outcomes but were backed by real cash.
We also excluded cyclical businesses, where earnings fluctuate sharply with economic conditions, and companies whose valuations still looked stretched even under optimistic assumptions.
As a result, only three companies passed our filters. Let’s break down their growth, past financials and the risks that may hinder their performance in the long run.
#1 CarTrade Tech
CarTrade Tech runs digital marketplaces across India’s automotive ecosystem. Its platforms connect vehicle buyers and sellers, help dealers source inventory and enable banks and NBFCs to auction repossessed vehicles. When the company was listed in 2021, expectations were high, and valuations reflected that confidence.
The business, however, took time to mature.
Over the past three years, revenues have grown at a healthy 25-30 per cent per annum. More importantly, profitability has improved sharply. EBITDA margins, once stuck in low single digits, have expanded as operating leverage kicked in. In FY25, profit growth outpaced revenue growth by a wide margin, reflecting tighter cost control and better monetisation.
Cash flows reinforce this improvement. Over the last three years, operating cash flows have consistently exceeded 60 per cent of EBITDA, indicating that profits are translating into cash rather than being absorbed by working capital or aggressive spending.
Looking ahead, CarTrade Tech’s growth hinges on three levers: 1) deeper monetisation of the dealer ecosystem through subscription-based and SaaS offerings, 2) higher auction volumes from banks and NBFCs managing repossessed vehicles and 3) cross-selling across platforms, which can lift revenue per participant without a matching rise in costs.
Yet, challenges persist. Competition among digital marketplaces remains intense, and pricing power can weaken quickly if customer acquisition costs rise. A slowdown in used-vehicle transactions would also reduce volumes. The market’s lower valuation reflects a simple demand: proof that recent profit gains are sustainable, not temporary.
#2 Acutaas Chemicals
Acutaas Chemicals operates in advanced pharmaceutical intermediates and specialty chemicals – segments where complexity, not scale, drives value. Unlike commodity chemical players, its growth has come from moving up the value chain.
Over the past three years, the pharma player’s revenues and profits have grown at over 25 per cent annually. EBITDA margins expanded sharply in FY24 and FY25 as new capacities ramped up and product mix improved.
Crucially, this growth has not strained cash flows. Despite ongoing capital expenditure, operating cash flows have remained above 50 per cent of EBITDA over the three-year period, reflecting disciplined working capital management.
Going forward, growth could come from higher utilisation of recently commissioned facilities, expansion into newer verticals such as battery chemicals and semiconductor-related chemicals, and deeper engagement with global customers through longer-term supply contracts. These areas have higher entry barriers and, if executed well, can support a longer growth runway.
But the risks are equally clear. Demand in specialty chemicals can be lumpy, customer concentration needs monitoring and newer verticals often take time to generate stable profits. The broader valuation reset in the chemicals sector suggests the market is cautious, keen to see whether current margins represent a new normal or a peak-cycle phenomenon.
#3 Force Motors
Force Motors is best known as India’s largest van manufacturer. However, few know that the company also operates in shared mobility vehicles, specialised applications such as ambulances and defence vehicles and engine-manufacturing partnerships with global OEMs (original equipment manufacturers), including BMW and Mercedes-Benz.
After years of uneven performance, the past three years have seen a sharp recovery. Revenues have grown steadily, while profits have risen much faster, helped by a better product mix and operating leverage. In FY25, consolidated profits more than doubled year-on-year.
Cash generation has also improved meaningfully. Operating cash flows have tracked EBITDA closely and crossed the 50 per cent conversion threshold, aided by tighter working capital control and a moderation in capital intensity after earlier investments.
Force Motors’ growth could now come from scaling its premium van portfolio (Urbania), expanding exports and maintaining steady volumes from engine manufacturing partnerships. The company’s focus on specialised mobility rather than mass passenger vehicles helps limit exposure to intense price competition.
Still, risks remain. Demand for shared mobility vehicles can fluctuate with economic cycles, and dependence on a few large OEM partnerships concentrates risk, even if those relationships are long-standing. The valuation compression suggests investors want to see consistent performance across cycles, not just a post-turnaround surge.
What is the divergence trying to tell investors?
Across all three companies, the market’s message is consistent: growth alone is no longer enough. It must be durable, backed by cash and capable of surviving scale and scrutiny.
Valuation compression here is not a rejection of business quality. It is a demand for evidence.
For long-term investors, this creates a more grounded opportunity set. Not stories that rely on rerating, but businesses where steady execution and strong cash conversion can compound returns even if valuations remain restrained.
In a market that has stopped paying for belief, earnings – and the cash behind them – have to do the talking.
Want to find businesses that deliver on growth as well as execution?
Subscribe to Value Research Stock Advisor and get access to our list of recommended stocks that have not only compounded over time, but have also endured multiple market cycles, giving investors robust returns.
Also read: 4 fast-growing stocks to watch after their big correction
This article was originally published on December 26, 2025.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]





